Technical Analysis for ATXS - Astria Therapeutics, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 9.00 | -1.85% | -0.17 |
ATXS closed down 1.85 percent on Friday, April 26, 2024, on approximately normal volume. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline. Due to the stock's strong downtrend, it may remain oversold for a while. So, if you're looking for a reason to buy, don't put too much weight on it being oversold.
Earnings due: May 9
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Strong | Flat | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Fell Below 200 DMA | Bearish | 0.00% | |
| 180 Bearish Setup | Bearish Swing Setup | 0.00% | |
| Slingshot Bearish | Bearish Swing Setup | 0.00% | |
| Wide Bands | Range Expansion | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Crossed Above 200 DMA | Bullish | -1.85% | |
| Pocket Pivot | Bullish Swing Setup | -1.85% | |
| NR7 | Range Contraction | -1.85% | |
| Wide Bands | Range Expansion | -1.85% | |
| Oversold Stochastic | Weakness | -1.85% |
| Alert | Time |
|---|---|
| 60 Minute Opening Range Breakdown | about 12 hours ago |
| Fell Below 200 DMA | about 12 hours ago |
| Down 2 % | about 12 hours ago |
| Up 3% | about 17 hours ago |
| Up 2% | about 17 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/09/2024
Astria Therapeutics is a biopharmaceutical company, and our mission is to bring life-changing therapies to patients and families affected by rare and niche allergic and immunological diseases. Our lead program, STAR-0215, is a monoclonal antibody inhibitor of plasma kallikrein in preclinical development for the treatment of hereditary angioedema.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Clinical Medicine Life Sciences Immunology Monoclonal Antibody Antibody Angioedema Hereditary Angioedema Kallikrein Complement Deficiency
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Biopharmaceutical Clinical Medicine Life Sciences Immunology Monoclonal Antibody Antibody Angioedema Hereditary Angioedema Kallikrein Complement Deficiency
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 16.9 |
| 52 Week Low | 4.26 |
| Average Volume | 1,082,193 |
| 200-Day Moving Average | 9.00 |
| 50-Day Moving Average | 13.01 |
| 20-Day Moving Average | 10.84 |
| 10-Day Moving Average | 9.94 |
| Average True Range | 0.81 |
| RSI (14) | 25.93 |
| ADX | 30.35 |
| +DI | 12.76 |
| -DI | 30.31 |
| Chandelier Exit (Long, 3 ATRs) | 12.37 |
| Chandelier Exit (Short, 3 ATRs) | 11.19 |
| Upper Bollinger Bands | 13.20 |
| Lower Bollinger Band | 8.48 |
| Percent B (%b) | 0.11 |
| BandWidth | 43.48 |
| MACD Line | -1.14 |
| MACD Signal Line | -0.99 |
| MACD Histogram | -0.149 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 9.74 | ||||
| Resistance 3 (R3) | 9.81 | 9.63 | 9.61 | ||
| Resistance 2 (R2) | 9.63 | 9.45 | 9.60 | 9.57 | |
| Resistance 1 (R1) | 9.32 | 9.33 | 9.23 | 9.25 | 9.53 |
| Pivot Point | 9.14 | 9.14 | 9.10 | 9.11 | 9.14 |
| Support 1 (S1) | 8.83 | 8.96 | 8.74 | 8.76 | 8.47 |
| Support 2 (S2) | 8.65 | 8.84 | 8.62 | 8.43 | |
| Support 3 (S3) | 8.34 | 8.65 | 8.39 | ||
| Support 4 (S4) | 8.27 |
